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ABSTRACT
Widely used nucleic acid assays are poorly suited
for field deployment where access to laboratory
instrumentation is limited or unavailable. The need
for field deployable nucleic acid detection demands
inexpensive, facile systems without sacrificing
information capacity or sensitivity. Here we
describe a novel microarray platform capable of
rapid, sensitive nucleic acid detection without
specialized instrumentation. The approach is
based on a miniaturized lateral flow device that
makes use of hybridization-mediated target
capture. The miniaturization of lateral flow nucleic
acid detection provides multiple advantages over
traditional lateral flow devices. Ten-microliter
sample volumes reduce reagent consumption and
yield analyte detection times, excluding sample
preparation and amplification, of _120s while
providing sub-femtomole sensitivity. Moreover, the
use of microarray technology increases the poten-
tial information capacity of lateral flow. Coupled
with a hybridization-based detection scheme, the
lateral flow microarray (LFM) enables sequence-
specific detection, opening the door to highly
multiplexed implementations for broad-range
assays well suited for point-of-care and other field
applications. The LFM system is demonstrated
using an isothermal amplification strategy for
detection of Bacillus anthracis, the etiologic agent
of anthrax. RNA from as few as two B. anthracis
cells was detected without thermocycling hardware
or fluorescence detection systems.
INTRODUCTION
The challenges presented by biological weapons, global
health-care issues and emerging diseases of natural origin
lend urgency to the development of rapid, ﬁeld-deployable
pathogen detection and diagnostic tools (1,2). Ideally,
to be of general ﬁeld utility, a diagnostic device must be
capable of sensitive and speciﬁc pathogen detection
while retaining simplicity of use and independence from
complex laboratory instrumentation (3). Additional chal-
lenges are presented by the need to screen samples for
multiple pathogenic or toxic agents, a characteristic
highly desirable in cases where commonalities in early
symptom presentation confound diﬀerential diagnoses.
While nucleic acid-based assays for pathogen detection
and identiﬁcation oﬀer sensitivity, speciﬁcity and resolu-
tion, they are relatively elaborate and often costly,
limiting their utility for point-of-care diagnostics and
deployment under ﬁeld conditions where a supporting
laboratory infrastructure is limited or absent. Reliance
upon polymerase chain reaction (PCR) and ﬂuorescent
detection of ampliﬁed nucleic acids has contributed
signiﬁcantly to the complexity and cost of nucleic acid
diagnostics (2,4–6). Retaining assay sensitivity while
circumventing requirements for thermocyclers and
ﬂuorescence detection hardware remains a signiﬁcant
challenge.
The recent advent of DNA microarray technology has
promised to increase the information capacity of nucleic
acid diagnostics and enable the highly multiplexed
detection of genetic signatures (7). The potential of
DNA microarrays to detect, in parallel, large panels
of distinct nucleic acid sequences has proven to be a
powerful technique for many laboratory applications (8).
Nonetheless, the reliance of this technology on costly
instrumentation for high-resolution ﬂuorescence signal
transduction severely limits the utility of microarrays for
ﬁeld applications where a laboratory infrastructure is
limited or unavailable. Additionally, the long hybridiza-
tion incubations required for microarray assays increase
sample-to-answer times beyond what would be acceptable
for a rapid screening assay. Though microarray hybridi-
zation times as short as 300 and 500s have been reported
(9,10), such methods employ designs that remain reliant
upon ﬂuorescent detection and supporting instrumenta-
tion and do not address the need for low-cost, easily
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laboratory infrastructures.
In contrast to DNA-based assays, immunoassays have
found widespread acceptance in low-cost, easily used
formats, perhaps the most notable of which is the
chromatographic lateral ﬂow immunoassay (11). Lateral
ﬂow assays, also known as hand-held assays or dipstick
assays, are used for a broad range of applications where
rapid antigen detection is required in an easily used,
low-cost format. Expanding the domain of lateral ﬂow
chromatography to nucleic acid detection, a number
of recent reports have described lateral ﬂow detection of
PCR products using a variety of capture and detection
schemes (12–15). Unfortunately, the utility of lateral ﬂow
detection in the context of a PCR-based assay is severely
limited by the fact that reliance on thermocycling
hardware largely negates the potential beneﬁt of the
otherwise highly simpliﬁed lateral ﬂow platform.
Additionally, a PCR-based approach to lateral ﬂow
detection necessitates each PCR reaction be subjected
to post-ampliﬁcation manipulations required to generate
single-stranded products for hybridization-based
detection.
Recent work has sought to alleviate reliance on PCR
through employing isothermal nucleic acid ampliﬁcation
schemes or direct detection of unampliﬁed genetic
material. Enabled by the use of up-converting phosphor
reporters, unampliﬁed Streptococcus pneumoniae DNA
sequence has been detected using a lateral ﬂow assay
format (16). Up-converting phosphor technology, while
sensitive, remains dependent upon the hardware required
to detect phosphor emission (17). The use of simple
colorimetric detection schemes that circumvent the
requirements for complex instrumentation require an
upstream ampliﬁcation strategy to attain suitable sensi-
tivity. Isothermal nucleic acid ampliﬁcation coupled
with lateral ﬂow detection has been reported for assays
making use of cycling probe technology [CPT, (18)],
recombinase polymerase ampliﬁcation [RPA, (19)]
and nucleic acid sequence-based ampliﬁcation [NASBA,
(20–27)]. While the work by Fong et al. (23) and
Piepenburg et al. (19) made use of a lateral ﬂow
immuno-assay for DNA detection, the RNA targets
ampliﬁed by NASBA in the work from Baeumner’s
group (24–27) were detected using a lateral ﬂow system
enabled by the use of liposome encapsulated dye and
a sandwich hybridization assay similar to that reported
by Rule et al. (13). While shown to display nanomolar
sensitivity, the reported dye encapsulating liposome-
based methods require additional washing steps and
the liposomes are relatively labile, must be custom
synthesized, and stored under stabilizing hydrated
conditions (28).
To develop more capable nucleic acid detection
methods that oﬀer many of the advantages of microarray
technology yet retain the simplicity of lateral ﬂow-based
platforms, we have developed a microarray-based lateral
ﬂow technology. Using an assay based on the nonsense
mutation in the plcR gene of Bacillus anthracis, that is
absent in the near phylogenetic neighbors B. thuringiensis
and B. cereus (29,30), we illustrate the utility of the lateral
ﬂow microarray (LFM) approach for sensitive detection
and discrimination of closely related microbial signatures
when present as minority sequences in complex nucleic
acid mixtures. The results demonstrate that LFMs,
making use of stable detection reagents suitable for dry
storage, can be used to detect as little as 250amol analyte
within 2min of sample addition. The miniaturization of
lateral ﬂow detection decreases reagent consumption and
sample-to-answer times while increasing the potential
information capacity of the platform to enable the
development of highly multiplexed nucleic acid detection
assays.
MATERIALS AND METHODS
RNA isolation
Total RNA was isolated from B. anthracis strain Sterne
7702 and B. thuringiensis strain HD 621 (31) using
a previously reported protocol (32). Puriﬁed RNA was
quantiﬁed by measuring OD260 and evaluated by gel
electrophoresis. 3 10
8 cells were used for RNA isolation
typically yielding 50–75mg of total RNA.
Amplification primer design
NASBA (22) primers, plc-P1 and plc-P2, were designed to
amplify a fragment of the plcR locus from B. anthracis.
Primer sequences used for NASBA reactions are provided
in Table 1, the T7 promoter sequence is italicized in
plc-P1. Plc-P1 hybridizes to the plcR transcript such that
the 30-end of the primer forms a base pair with the
previously reported polymorphism strictly associated with
B. anthracis (29,30). The NASBA P2 primer, plc-P2,
is located such that the ampliﬁed RNA resulting from
NASBA is 179 bases in length (Figure 1A). Previously
reported plcR-based B. anthracis real-time PCR assays
(29,30) have made use of an alternate upstream primer
that generates a 83bp product but may be poorly suited
for NASBA given the optimal NASBA product size
of 120–250 bases (33).
Nucleic acid sequence-based amplification (NASBA)
NASBA reactions were prepared according to the
manufacturer’s instructions using the NucliSens Basic kit
(Biomerieux) and primers plc-P1 and plc-P2at 0.4mM
each. Amounts of total cellular bacterial RNA were
varied, as indicated, between 0 and 2ng. Bacillus anthracis
Sterne 7702 was used as a test strain and B. thuringiensis
strain HD 621 was employed as a negative control.
One microgram of human total cellular RNA isolated
from HeLa S3 cells (Stratagene) was included in all
NASBA reactions to provide a complex RNA background
consistent with the composition of human diagnostic
samples. Following a 60-min incubation at 418C, NASBA
reaction products were detected by using a LFM.
LFM fabrication
LFMs were printed using a NanoPlotter 2.0 (GeSim,
mbH, Dresden, Germany) non-contact picoliter deposi-
tion system equipped with NanoTips (GeSim).
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400mM solutions of oligonucleotide in H2O containing
a 1:50 dilution of Ponceau S (P7767, Sigma) as a tracking
dye. A lateral ﬂow compatible nitrocellulose membrane
(HiFlow 135, Millipore) was used as the LFM substrate.
Following oligonucleotide deposition, nitrocellulose
membranes were air dried and exposed to 5000mJU Vi n
a StrataLinker (Stratagene). The resulting membrane
sheets were cut into 3-mm wide, 30-mm long strips,
which were either used directly with buﬀer-suspended
dyed microspheres or assembled with conjugate release
pads into a custom plastic housing. Housings were
fabricated from polycarbonate sheet cut using a CO2
laser (VersaLaser VL-300, Universal Laser Systems, Inc.,
Scottsdale, AZ, USA). A gasket of 500-mm thickness was
used to generate an internal chamber of suﬃcient size to
accommodate the LFM substrate and the conjugate
release pad. The small sample volumes used obviated
the need for sample and downstream absorbent pads,
the function of which was supplied by the conjugate
release pad and unpatterned regions of the LFM
substrate, respectively. Conjugate release pads were
made by impregnating glass ﬁber conjugate pad
(GFCP203000, Millipore) with dyed microspheres cova-
lently conjugated to R-57-76-3TN in 1% SDS. Conjugate
release pads measuring 3.5mm 4.5mm were doped
with  8 10
9 oligonucleotide conjugated dyed micro-
spheres. Microsphere saturated release pads were allowed
to air dry under ambient conditions prior to assembly
with LFM membranes.
Colorimetric hybridization sandwich assayreagents
Table 1 provides capture and detection oligonucleotide
sequences, their binding sites within the plcR amplicon are
depicted in Figure 1B. Amine modiﬁcation and a T18
spacer sequence were included on the 30-end of detection
oligonucleotide R-57-76-3TN to allow covalent cross-
linking to dyed microspheres and to facilitate hybridiza-
tion in lateral ﬂow sandwich assays, respectively.
SPHERO
TM carboxyl-polystyrene 0.35-mm blue micro-
spheres (Spherotech) were covalently conjugated to amino
modiﬁed oligonucleotide R-57-76-3TN using the coupl-
ing agent 1-etyl-3-(3-dimethylaminopropyl-diimide HCl)
(EDAC, Pierce) under conditions adapted from
Spiro et al. (34). Brieﬂy, 1.1 10
12 microspheres were
suspended in 100mM 2-(N-morpholino)ethanesulfonic
acid pH 4.5 (MES, Sigma). Indicated amounts of
oligonucleotide were introduced to MES suspended
microspheres, vortexed and incubated in the presence of
0.5mg/ml EDAC. Reactions were protected from light in
aluminum foil wrapped tubes and incubated at room
Table 1.
Function Name Sequence
Bead Conjugation/Detection Probe R-57-76-3TN 50-AGGTGAGACATAATCATGCA TTTTTTTTTTTTTTTTTT-NH2-30
Detection Probe/Negative Control R-57-76-3N 50-AGGTGAGACATAATCATGCA-NH2-30
LFM Immobilized Capture Probe R-77-96 50-TAATAAAGAGTTTGATGTGA-30
LFM Immobilized Capture Probe R-36-55 50-AAGCATTATACTTGGACAAT-30
LFM Immobilized Capture Probe R-24-43 50-TGGACAATCAATACGAATAA-30
Synthetic target/Positive Hyb Control dnaR89 50-CAAAGCGCTTATTCGTATTGATTGTCCAAGTATAATGCTTTTGC
ATGATTATGTCTCACCTTCACATCAAACTCTTTATTATCATGTAA-30
NASBA/In vitro transcription product plcRivt 50-GGGAGAUUUGCAUGACAAAGCGCUUAUUCGUAUUGAUUGU
CCAAGUAUAAUGCUUUUGCAUGAUUAUGUCUCACCUUCACAU
CAAACUCUUUAUUAUCAUGUAAUACUUCUAAUUGCUUUAAUA
UAUUUUCAUAUAACUCAAUACUCUUCUUAAAAUGGCCAUUUU
CAGCGUAAAUGUU-30
Negative Hyb Control FT-S18 50-GCGGTCCCAAAAGGGTCAGTCGTAGCACACCACTTTCA-30
Negative Hyb Control F-24-43 50-TTATTCGTATTGATTGTCCA-30
NASBA-P1/Allele Discrimination plc-P1 50-TTCTAATACGACTCACTATAGGGAGATTTGCATGACAAAGCGCTTA-30
NASBA-P2 plc-P2 50-AACATTTACGCTGAAAATGGCCA-30
Figure 1. (A) NASBA primer-binding sites are shown in the relevant region of the predicted B. anthracis plcR mRNA sequence based on GenBank
accession number AY265698. The terminal 30 base of plc-P1 is complementary to the U of the ochre stop codon, indicated with an arrowhead,
diagnostic for B. anthracis.( B) The predicted nucleotide sequence plcR mRNA in the region represented by synthetic target dnaR89. The binding
sites of detection probe R-57-76-3TN, as well as capture probes R-77-96, R36-55 and R-24-43 are indicated.
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additional EDAC to bring the ﬁnal EDAC concentration
to 1 mg/ml. Incubation was continued for an additional
30min after which beads were washed once with 1ml
0.02% tween-20 (Sigma) and twice with 0.5ml 0.1% SDS
(Fisher Scientiﬁc). Beads were re-suspended in 0.5ml
DNAase/RNAase free H2O. Bead suspensions were
assessed for aggregation by phase-contrast light micro-
scopy using a Zeiss IM135 inverted microscope.
LFMassays
A DNA oligonucleotide, dnaR89, composed of sequence
derived from a region of the plcR gene of B. anthracis,
as shown in Figure 1B, was used to provide a readily
available and quantiﬁable target for LFM assay develop-
ment and optimization. The sequence of this synthetic
target is provided in Table 1. Additionally, a full-length
synthetic target RNA was generated. This RNA, referred
to here as plcRivt, was used to conﬁrm that reaction
conditions established with dnaR89 were also suitable for
the detection of NASBA reaction products. Synthesis of
plcRivt was accomplished by using plc-P1 and plc-P2
primers in PCR reactions containing 20ng of B. anthracis
Stern strain 7702 genomic DNA. PCR reactions using
Platinum PCR Supermix (Invitrogen) were conducted
for 40 cycles of 948C for 30s, 608C for 30s and 728C for
1min following an initial 2-min incubation at 948C.
The resulting amplicon was subjected to puriﬁcation
using QIAquick PCR clean-up spin-columns (QIAGEN)
and subsequently used to program an in vitro transcrip-
tion reaction using the T7 AmpliScribe kit (EpiCentre).
The in vitro transcription reaction product was subjected
to treatment with RNase free DNase I (Ambion) and
puriﬁed using a RNeasy column (QIAGEN). The result-
ing RNA was quantiﬁed by measuring the OD260. plcRivt
is predicted to be identical in sequence to the NASBA
product generated from B. anthracis total cellular RNA
using plc-P1 and plc-P2.
Detection of NASBA reaction products by LFM was
accomplished by introducing a 2-ml aliquot of a 20-ml
NASBA reaction into 8ml of LFM running buﬀer. Lateral
ﬂow running buﬀer was based on the widely used standard
sodium citrate buﬀer (SSC; 1 SSC¼150mM NaCl,
15mM sodium citrate, pH 7.0) supplemented with 1.4%
Triton X-100 and 0.1% SDS to reduce microsphere
aggregation and 5% formamide to increase hybridization
stringency and destabilize target secondary structure
(ﬁnal buﬀer composition: 4 SSC, 0.1% SDS, 1.4%
Triton X-100, 5% deionized formamide). The ﬁnal
volume of solution applied to LFMs was 10ml.
Following completion of sample ﬂow, LFM membranes
were removed from plastic housings and allowed to air dry
prior to scanning with a standard ﬂatbed PC scanner
(CanoScan 9950F, Canon, Inc.). Scans were performed
at 2400dpi resolution using 48-bit color. The resulting
image ﬁles were converted to grayscale, inverted and saved
as 16-bit TIFF ﬁles using Photoshop CS2 (Adobe).
Image ﬁles were analyzed using GenePix Pro 6.0
(Molecular Devices) to quantify microarray spot
intensities for NASBA product detection and for
dnaR89 dilution series experiments.
For time course studies, LFM assays were conducted
with sample buﬀer containing 0.1% w/v suspended dyed
microspheres ( 4 10
9 particles) in running buﬀer.
Lateral ﬂow was recorded using a digital video recorder
(DCR-PC1, Sony). Video frames were collected for
quantiﬁcation using iMovie (Apple Computer). Feature
intensity was quantiﬁed for time course studies and some
optimization experiments using uncalibrated optical
density in ImageJ (http://rsb.info.nih.gov/ij/). For better
reproduction contrast, LFM images used for ﬁgures were
cropped and modiﬁed by applying the Auto Contrast
function in Photoshop CS2. No other modiﬁcations
were applied.
RESULTS
LFM prototype
Oligonucleotides for hybridization sandwich assays were
designed to detect NASBA ampliﬁed B. anthracis plcR
mRNA or synthetic targets based on relevant subregions
of the plcR sequence. Oligonucleotides immobilized on the
lateral ﬂow substrate are referred to here as capture
oligonucleotides while those conjugated to dyed micro-
spheres for signal generation are referred to here as
detection oligonucleotides. Supported large-pore nitrocel-
lulose membranes were patterned with varying concentra-
tions of capture oligonucleotides using a NanoPlotter 2.0
robotic positioning system and NanoTip piezoelectroni-
cally actuated micropipets. Oligonucleotide dnaR89 was
printed on LFM substrates as a positive hybridization
control as this oligonucleotide carries sequence comple-
mentary to bead coupled detection oligonucleotide
R-57-76-3TN. Negative hybridization control oligo-
nucleotides included the reverse complement of capture
oligonucleotide R-24-43 (F-24-43), the detection probe
sequence sans T18 spacer (R-57-76-3N) and a plcR
unrelated sequence complementary to a region of the
Francisella tularensis sdhA locus (FT-S18). By ejecting
droplets from the micropipet at a distance of 500mm from
the nitrocellulose substrate, microarray feature sizes of
 200mm could be generated. In contrast to contact
microarray printing methods, this approach preserves
the fragile pore structure of the membrane required for
microsphere-based detection. Patterned nitrocellulose
sheets were cut into 3-mm wide strips and then assembled
with conjugate release pads in a custom designed plastic
housing. An example of the resulting device is shown in
Figure 2A. Hybridization-mediated capture of analyte at
the cognate capture element of the microarray and non-
overlapping hybridization to dyed microsphere conju-
gated detection oligonucleotide generates a colorimetric
signal arising from an increased local concentration of
dyed microsphere particles. In the absence of hybridiza-
tion, microspheres are suﬃciently dispersed that addi-
tional washing steps are not required to reduce
background signal levels. A schematic representation of
the hybridization sandwich assay scheme is depicted in
Figure 2B.
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LFMs were fabricated using varying concentrations of
capture oligonucleotide to determine optimum printing
concentrations. Following lateral ﬂow of 25fmol dnaR89
in 4  SSC, 5% formamide, 1.4% Triton X-100, 0.1%
SDS containing 0.1% R-57-76-3TN coupled microspheres
LFMs were scanned on a ﬂatbed scanner and the resulting
images quantiﬁed. For all capture sequences examined,
400-mM oligonucleotide-printing concentrations provided
the most favorable signal intensity (Figure 3A). Standard
hybridization conditions employed for these and other
characterization studies were determined through an
iterative set of optimization experiments that examined
the eﬀects of ionic strength, formamide concentration and
detection oligonucleotide to bead cross-linking ratios.
Given the profound impact ionic strength has on the
stringency of DNA hybridization, microsphere dispersion
and lateral ﬂow characteristics, SSC concentration was
varied from 1 to 9 and assay performance evaluated
by densitometry of LFMs following hybridization sand-
wich assays conducted using 25fmol of the synthetic
target dnaR89 or  200fmol of plcRivt (35,36). Figure 3B
summarizes the results of SSC concentration optimization
experiments. Near optimal signal intensity was obtained
for both dnaR89 and plcRivt at SSC concentrations
between 2  and 7 . For use in standard LFM running
buﬀer 4  SSC was selected as it provided sensitive
hybridization-based detection of plcR derived sequences,
good capillary lateral ﬂow characteristics, and favorable
microsphere dispersion and release-pad liberation.
Formamide is known to reduce the melting temperature
of DNA and RNA duplexes and may facilitate capture
and detection probe accessibility to binding sites within
the target through a destabilization of analyte secondary
structure (37). To determine the optimum concentration
of formamide in LFM running buﬀer, a series of LFM
experiments were conducted at varying formamide
concentrations using both dnaR89 and plcRivt. 10mlo f
4  SSC, 1.4% Triton X-100 and 0.1% SDS containing
25fmol dnaR89 or  200fmol plcRivt and varying
concentrations of formamide, as indicated in Figure 3C,
were subjected to LFM analysis and the resulting
hybridization signals quantiﬁed by densitometry. These
experiments revealed a slight but reproducible increase
in signal intensity at 5% formamide. All subsequent
studies presented here were performed using 4  SSC,
1.4% Triton X-100, 0.1% SDS and 5% formamide.
Given that higher stock concentrations of synthetic
oligonucleotide dnaR89 could be obtained, which allowed
high conﬁdence quantiﬁcation of this synthetic target
relative to what could be achieved with comparatively
dilute solutions of the in vitro transcription product
plcRivt, subsequent LFM characterization studies made
use of dnaR89. The similarity of buﬀer optima displayed
by dnaR89 and by plcRivt synthetic targets supported the
assertion that dnaR89 could be used as an accurate proxy
for the performance of LFM assays for NASBA product
detection. Others have reported similar ﬁndings conclud-
ing that appropriately designed DNA oligonucleotides can
be used as synthetic targets for the development of assays
ultimately used for NASBA product detection (38).
Therefore, subsequent LFM assay optimization and
characterization was conducted using dnaR89.
To determine the optimum ratios for cross-linking
detection oligonucleotides to dyed polystyrene micro-
spheres, we examined populations of beads coupled to
oligonucleotide at varying ratios. The 30-amine modiﬁed
detection oligonucleotide R-57-76-3TN was covalently
linked to polystyrene dyed microspheres using EDAC.
The resulting bead/oligonucleotide complexes were eval-
uated for their ability to mediate detection of dnaR89 in a
hybridization sandwich assay. Coupling reactions using
a 2.2 10
4:1 oligonucleotide to bead ratio were found to
provide optimum signal as determined by densitometry
(Figure 3D).
Characterization ofLFM-based nucleic acid detection
sensitivity
The detection oligonucleotide R-57-76-3TN carried a
30-spacer region consisting of 18T residues to increase
the accessibility of bead bound oligonucleotides for
hybridization. R-57-76-3N, which carried the same
analyte complementary sequence as R-57-76-3TN but
without the T18 spacer, was found to exhibit signiﬁcantly
reduced hybridization to dnaR89 consistent with prior
reports that a poly(dT) spacer sequence increases hybri-
dization eﬃciency to solid-phase coupled oligonucleotides
Figure 2. (A) A compact plastic housing was designed to a carry
conjugate release pad and a LFM membrane. A small port is used to
introduce the 10-ml sample volume and a rectangular window allows
direct visualization of the microarray capture features. The device is
39 5mm. (B) A schematic representation of the hybridization
sandwich assay used for LFM-based nucleic acid detection. Carboxyl-
polystyrene dyed microspheres are linked to amine-modiﬁed detection
oligonucleotide R-57-76-3TN. The microsphere/analyte complex forms
by hybridization as sample solution liberates dried microspheres from
the conjugate release pad. This complex is captured from solution by
hybridization to immobilized capture probes as capillary ﬂow trans-
ports the sample/bead solution through the large-pore nitrocellulose
matrix. The resulting increase in local microsphere concentration,
at capture features complementary to the target analyte, rapidly
produces a colorimetric signal visible to the naked eye and easily
detected at low concentrations using widely available ﬂatbed scanners.
The hybridization based nature of the assay render it well suited for
multiplexed detection.
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rated into LFM immobilized capture oligonucleotides
as they were found to be dispensable for hybridization.
To determine the relative performance of hybridization
sandwich assays making use of capture oligonucleotides
with complementarity to diﬀerent locations of the target
sequence, three capture oligonucleotides were synthesized
and compared using sandwich assays employing detection
oligonucleotide R-57-76-3TN coupled dyed microspheres.
R-77-96 was designed to participate in base stacking with
R-57-76-3TN when hybridized to the target. Base stacking
has been reported to stabilize hybridization and allow
eﬃcient capture of dilute nucleic acids by hybridization
(41–45). The binding sites for the three capture
Figure 3. (A) LFM substrates patterned with diﬀerent concentrations of capture oligonucleotides R-77-96, R-36-55, and R-24-43 were used to detect
dnaR89 with R-57-76-3TN microspheres. Signals generated at microarray capture features printed at 200, 400 and 800mM were quantiﬁed
following lateral ﬂow of samples containing 5, 10 and 20fmol dnaR89. Signals were normalized for each capture probe and target concentration.
Average signal intensities were calculated and presented in this bar graph. 400mM printing concentrations consistently provided the strongest signal
independent of capture sequence or dnaR89 concentration. Error bars are the 95% conﬁdence interval (two tailed, n¼12). (B) Scatter plot
of normalized signal intensity versus SSC concentration. LFM running buﬀer was optimized for SSC concentration using R-57-76-3TN to detect
dnaR89 (circles) or plcRivt (squares). (C) Line plot of normalized signal intensity versus formamide concentration. Formamide concentrations
between 0 and 20% in LFM running buﬀer based on 4  SSC were evaluated for dnaR89 (circles) and plcRivt (squares). Five percent formamide
provided near optimal detection of both dnaR89 and plcRivt. (D) Line plot of normalized signal intensity versus the R-57-76-3TN to microsphere
ratio. Oligonucleotides/bead of 2.2 10
4 in coupling reactions provided the best performing conjugated microsphere populations as judged by
hybridization sandwich assay signal intensity. For parts B–D error bars are the 95% conﬁdence interval (two tailed, n¼4).
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R-24-43) are illustrated in Figure 1B. Varying quantities
of synthetic target dnaR89, between 0 and 200fmol, were
used for these studies. Figure 4 depicts LFM membranes
following detection of the indicated amounts of target
oligonucleotide dnaR89. LFMs carried dnaR89, which
hybridizes directly to the microsphere conjugated detec-
tion probe, as a positive hybridization control. Positive
control features were printed as the left most element of
each LFM row to assist in feature identiﬁcation. Negative
hybridization controls, F24-43 and FT-S18, were based on
the reverse complement of R-77-96 and an unrelated
F. tularensis derived sequence, respectively. Additionally,
to conﬁrm that no carryover contamination occurred
during printing, H2O containing Ponceau S was printed
on LFM substrates between positive control and capture
oligonucleotide deposition. No signal was detectable
in either hybridization negative controls or H2O negative
control microarray elements.
Background corrected signal intensity was determined
from LFM images using GenePix Pro 6.0 microarray data
extraction software. The results, presented in Figure 5A,
reveal R77-96 produces signiﬁcantly higher hybridization
signals than R-36-55 or R-24-43 for all examined
quantities of dnaR89, suggesting a signiﬁcant contribution
of base stacking eﬀects to LFM hybridization sandwich
assay sensitivity.
To deﬁne the detection limit of the LFM assay,
a one-tailed t-test was used to determine quantities of
dnaR89 that generated signal intensities signiﬁcantly
above 0amol negative controls. Signals generated at
R-77-96 capture features with 250amol and greater
quantities of dnaR89 were signiﬁcantly 40amol dnaR89
controls (P50.05, n¼6). By the same criterion, 1fmol
dnaR89 detection limits were obtained for both R-24-43
and R-36-55 (P50.05, n¼6). Figure 5B depicts the
performance of LFM detection over 0 to 2500amol
dnaR89 range using the R-77-96/R-57-76-3TN capture/
detection probes. LFM detection exhibited excellent
linearity, R
2¼0.989, over this 10-fold range of target
molecules. While capture probe R-24-43 exhibited less
sensitivity than R-77-96, this capture probe displayed
excellent signal linearity between 2.5 and 100fmol
dnaR89, R
2¼0.968 (Figure 5C). These ﬁndings demon-
strate that the LFM capacity to display multiple capture
sequences can be used to simultaneously provide sensitive
detection and extend assay linearity through the use of
capture probes with diﬀering hybridization characteristics.
LFMdetection time course studies
The small sample volumes used for LFM detection and
the reduced surface area traversed during capillary
lateral ﬂow signiﬁcantly reduces detection times for
Figure 4. Representative LFMs are shown following detection of the indicated amounts of dnaR89. The microarray physical layout is provided in
the color legend. The panel labeled ‘Ponceau S’ is an LFM prior to sample addition. Ponceau S allows visualization of successful oligonucleotide
deposition but migrates away from the capture zone during sample transport across the substrate. Contrast was adjusted using the Auto Contrast
function in Photoshop CS2 to increase reproduction contrast. Auto Contrast adjustment was not used for images subjected to quantiﬁcation. The bar
is 600 mm for all LFM panels.
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To quantitatively present the speed of LFM nucleic acid
hybridization-based detection, we used digital video to
follow hybridization sandwich assay-mediated detection
of synthetic target molecule dnaR89. Individual frames
were isolated from video datasets and quantiﬁed for
relative signal intensity over the course of capillary lateral
ﬂow across the LFM substrate. The resulting signal data
was plotted versus time in seconds as shown in Figure 6.
For time measurements, t0 was deﬁned as the time when
the sample front reached the ﬁrst row of LFM features.
Signal was detectable for 1000-fmol target in 2s following
sample transport across R-77-96 capture elements. Within
4s 100fmol dnaR89 was detectable while 10fmol was
clearly detectable by 30s as deﬁned by the earliest time
point at which 90% of the pixels composing the R-77-96
microarray features were greater than one standard
deviation above background. Lateral ﬂow transport of
the 10-ml sample was complete by 120s.
Allele-specific Isothermal Amplification and LFM-based
Product Detection
Prior reports have described a single nucleotide poly-
morphism (SNP) present in B. anthracis but not close
phylogenetic near neighbors including B. cereus and
B. thuringiensis (29,30). This SNP has been used as the
basis for a sensitive and highly discriminatory real-time
PCR assay for B. anthracis (30). To determine the utility
of LFM technology for detecting minority nucleic acids in
complex samples, NASBA primers were designed to
amplify the plcR allele of B. anthracis. P1 and P2 primer
sequences, plc-P1 and plc-P2, used for NASBA ampliﬁca-
tion are provided in Table 1 and their binding positions
illustrated in Figure 1.
Varying amounts of total cellular RNA isolated from
B. anthracis or 2ng of B. thuringiensis HD 621 RNA as
a negative control were introduced to 1mg of total human
cellular RNA isolated from HeLa S3 cells. The resulting
Figure 5. (A) The relative performance of three diﬀerent capture
oligonucleotides (R-77-96, circle/solid line; R-36-55, square/solid line;
R-24-43, diamond/dashed line) was determined using varying amounts
of dnaR89 from 0 to 200fmol. The capture probe R-77-96 provides
signiﬁcantly more sensitive detection than the other capture sequences
evaluated using R-57-76-3TN coupled microspheres. (B) R-77-96 signal
intensity versus amol dnaR89 from 0 to 2500amol is plotted with
a linear regression line (R
2¼0.989). (C) R-24-43 signal intensity versus
fmol dnaR89 from 2.5 to 100fmol plotted with a linear regression line
(R
2¼0.968). For all parts error bars are the 95% conﬁdence interval
(one tailed, n¼6).
Figure 6. Time course of LFM detection: 10-ml samples containing
either 1000fmol (circle), 100fmol (square) or 10fmol (diamond)
dnaR89 were run on appropriately patterned LFMs. Video data were
collected and colorimetric signal intensity measured from video frames
at R-77-96 capture features. Capillary transport of the 10-ml sample was
complete by 120s. Lines represent logarithmic curve ﬁts to the data.
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plc-P1 and plc-P2 primers. Human RNA was included
in NASBA ampliﬁcation reactions to approximate the
nucleic acid complexity expected in human diagnostic
specimens. An aliquot of 2ml of NASBA reaction mixture
was removed after a 60-min incubation at 418C, mixed
with 8ml of LFM running buﬀer and assayed for plcR
amplicon by LFM. Dyed microspheres cross-linked to
R-57-76-3TN were used for detection of NASBA ampli-
cons captured on LFMs carrying R-77-96. Data from
these studies are presented in Figure 7. Following 60min
of NASBA ampliﬁcation, as little as 0.5pg for total
cellular B. anthracis RNA could be detected in a
background matrix of 1mg of human total RNA. These
studies closely approximate the conditions expected
for complex human diagnostic samples and reveal the
capacity of the LFM platform to speciﬁcally detect
NASBA reaction products generated from mixed samples
where the target sequence is a minority species. While the
number of plcR mRNA copies in a B. anthracis cell has
not been determined, an estimate of LFM assay sensitiv-
ity, in terms of B. anthracis cells, can be calculated based
on total RNA yields. Total RNA yields from vegetative
B. anthracis were in the range of  167–250fg RNA/cell.
Using this value, an estimate of LFM sensitivity corre-
sponds to the detection of approximately to 2–3
B. anthracis cells.
DISCUSSION
Lateral ﬂow detection of DNA or RNA ampliﬁcation
reaction products provides one means of simplifying
nucleic acid detection. Indeed, a lateral ﬂow platform
may oﬀer many signiﬁcant advantages for employing
nucleic acid assays under conditions where a fully
equipped molecular biology laboratory infrastructure is
not available or desirable. Such situations would include
resource poor settings, point-of-care, battleﬁeld deploy-
ments and scenarios where ﬁrst responders must quickly
determine the threat presented by an unknown substance.
To date, however, lateral ﬂow devices have predominantly
been fabricated using one or a few capture lines thus
limiting the information capacity of the device to
one or a few analytes (14,27). As a step toward higher
information-content lateral ﬂow nucleic acid detection, we
have developed nitrocellulose-patterning methods that
enable microarray feature density to be attained on
lateral ﬂow compatible substrates. Making use of a
non-contact peizo actuated picoliter deposition system,
we have patterned lateral ﬂow compatible nitrocellulose
membranes with features similar in size and spacing
to those typically found on spotted glass microarrays.
The sensitivity of lateral ﬂow nucleic acid detection
methods previously reported in the literature has been
in the order of 1fmol (25). We ﬁnd that the LFM
platform provides rapid detection of as little as 250amol
of target using a low-cost and widely available ﬂatbed
scanner, a standard personal computer system and a
commercially available microarray data extraction suit
or free image analysis software. This detection limit
is similar to the sensitivity reported for ﬂuorescence
and chemiluminescence microarray detection strategies
(9,46). While the LFM implementation reported here
exhibits excellent linearity (R
2¼0.989), the linear dynamic
range is less than that commonly associated with
Figure 7. (A) Indicated amounts of total cellular RNA from
B. anthracis Sterne strain 7702 or, as a negative control, 2ng
B. thuringiensis strain HD 621 RNA (0fg panel) were introduced to
1mg of total human cellular RNA isolated from HeLa S3 cells. RNA
mixtures were subjected to NASBA ampliﬁcation for 60min after
which 2ml aliquots of the NASBA reactions were mixed with 8mlo f
LFM running buﬀer and introduced to LFMs. Enlarged LFM sub-
regions are shown following cropping, grayscale conversion and Auto
Contrast adjustment in Photoshop. The legend indicates microarray
element identities: (þ) dnaR89 as a positive hybridization control,
(–) R-57-76-3N as negative hybridization control, (24–43) capture
probe R-24-43, (36–55) capture probe R-36–55, (77–96) capture probe
R-77-96. (B) Graph of quantiﬁed signals from B. anthracis and
B. thuringiensis challenged LFMs with linear regression line
(R
2¼0.970). 0fg B. anthracis total cellular RNA data point contains
2ng B. thuringiensis total cellular RNA in addition to 1mg human
total cellular RNA. Error bars depict measurement SD (three
determinations).
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schemes and the use of capture probes of diﬀering hybridi-
zation characteristics should enable greater dynamic range
while retaining the simplicity of the LFM approach.
Indeed, examining the signals generated by R-77-96 and
by R-24-43, the eﬀective linear range of the LFM assay
extends over a 400-fold range of target from 250 to
100fmol (Figure 5B and C). The information density of
the LFM oﬀers the capacity for additional capture probes
of varying hybridization potential to be included that
should allow this dynamic range to be extended further.
The uniformity of sample ﬂow exhibited by the LFM
suggests that larger capture probe sets can be accommo-
dated without complications arising from physical factors.
For example, concentrations of analyte 40-fold above
the linear range of R-77-96 did not adversely impact the
linearity of R-24-43 signal at LFM elements situated
directly downstream (with respect to sample ﬂow) of
R-77-96 capture features (Figure 5B and C). Only at
artiﬁcially high microsphere capture densities, such as
those produced by the positive control hybridizations
in Figure 4, are signal gradients observed as a function
of physical location on the LFM, presumably due to
physical occlusion of membrane pores by high local
accumulations of microspheres.
LFMs oﬀer several advantages arising directly from
the miniaturization of the system without sacriﬁcing
detection sensitivity. While traditional lateral ﬂow assays
make use of sample volumes in the order of hundreds of
microliters to milliliters, the miniaturization approach
we have developed reduces sample volume to 10ml. This
reduced sample volume signiﬁcantly decreases the con-
sumption of reagents required for ampliﬁcation. Here we
have made use of 2ml of a NASBA reaction diluted to 10ml
in running buﬀer. By reducing standard NASBA reaction
volumes from 20 to 2ml, a one order of magnitude reduc-
tion in enzyme consumption is realized. It should also be
noted that other ampliﬁcation schemes, such as those
that make use of microﬂuidic systems or lab-on-a-chip
technologies, could be integrated with a miniaturized
lateral ﬂow-based detection system to provide a rapid and
cost-eﬀective means of detecting analytes.
A further beneﬁt of miniaturization is the time required
to detect analyte following introduction of ampliﬁed
material to the LFM. While the procedures used here
employed NASBA ampliﬁcation and traditional RNA
isolation protocols requiring  90min to complete, more
recent advances in nucleic acid preparation and ampliﬁca-
tion have reported signiﬁcant reduction in sample proces-
sing times (47). As ampliﬁcation protocols become more
rapid, the speed with which amplicons can be detected,
without complex optical systems and ﬂuorescent detec-
tion, becomes critical to realizing the potential of these
technologies. The LFM methods described here detect
nucleic acid analytes in less than 2min. Given that
250amol is equivalent to 1.5 10
8 molecules, eﬃcient
ampliﬁcation methods that oﬀer 10
9-fold ampliﬁcation,
widely cited ampliﬁcation levels for PCR- and NASBA-
based techniques (22,48), would theoretically enable the
detection of single-copy targets by LFM following
ampliﬁcation. Future systems that couple advanced
ampliﬁcation technologies and compatible streamlined
nucleic acid preparation modalities with rapid LFM
detection will allow signiﬁcant decreases in sample-to-
answer times without costly or complex instrumentation.
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